Product Information
TEMAZEPAM 30 MG CAPSULE is a generic product labeled by Solco Healthcare US LLC, priced at $0.0908 per EA under NDC 43547061450. Its NADAC has been published 158 times since Aug 16, 2023.
FDA first approved this application on Jun 4, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547061450
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TEMAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA201781FDA Approved
6/4/2015
TE Code
AB
On Market Since
1/5/2023
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 30 MG CAPSULE has been published 158 times since Aug 16, 2023, and over the history we have for it it has declined 2.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0908 per EA |
|---|---|
| All-time high | $0.0965 (Oct 16, 2024) |
| All-time low | $0.0726 (Nov 20, 2024) |
| 52-week high | $0.0926 |
| 52-week low | $0.0894 |
| Median price | $0.0904 |
| Average price | $0.0882 |
| Largest weekly change | -20.4% (Nov 20, 2024) |
| Weeks tracked | 158 |
| Tracking since | Aug 16, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TEMAZEPAM 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 30 MG CAPSULE, manufactured by Solco Healthcare US LLC, is $0.0908 per EA (NDC 43547061450), effective Aug 19, 2026.
How has the price of TEMAZEPAM 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 30 MG CAPSULE has declined 2.2%. It has been tracked across 158 weekly CMS publications since Aug 16, 2023.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 30 MG CAPSULE?
Since Aug 16, 2023, the NADAC for TEMAZEPAM 30 MG CAPSULE has ranged from a low of $0.0726 (Nov 20, 2024) to a high of $0.0965 (Oct 16, 2024), with a median of $0.0904 per EA.
Are there cheaper alternatives to TEMAZEPAM 30 MG CAPSULE?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TEMAZEPAM 30 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TEMAZEPAM 30 MG CAPSULE?
TEMAZEPAM 30 MG CAPSULE (NDC 43547061450) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.